» Articles » PMID: 2105494

Insulin, Oxytocin, and Vasopressin Stimulate Protein Kinase C Activity in Adipocyte Plasma Membranes

Overview
Specialty Science
Date 1990 Feb 1
PMID 2105494
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Incubation of isolated rat adipocytes with insulin, vasopressin, or oxytocin increased plasma membrane-bound protein kinase C (PKC) activity by 100-400%. PKC activity was assayed by a procedure that is virtually background-free, thus permitting assay of protein kinase activity in highly diluted samples of solubilized membranes. Hormone-dependent increases in PKC activity were limited to plasma membranes. Stimulation of the kinase was half-maximal with 70 pM insulin, and the hormone effect was rapid. Oxytocin and vasopressin produced effects on PKC similar to insulin, but the magnitude of the vasopressin stimulation exhibited seasonal variations. Treatment of cells with phorbol 12-myristate 13-acetate (PMA) resulted in a loss of PKC activity from the cytosol and a gain in plasma membrane activity, indicative of translocation of the enzyme. With activity measurements it was not possible to determine if insulin stimulated a translocation of the kinase. However, Western blot analysis of plasma membranes with polyclonal antibodies directed against PKC suggest that at least some of the insulin-stimulated PKC activity resulted from enzyme translocation.

Citing Articles

Molecular Interaction Between Vasopressin and Insulin in Regulation of Metabolism: Impact on Cardiovascular and Metabolic Diseases.

Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Zera T Int J Mol Sci. 2025; 25(24.

PMID: 39769071 PMC: 11678547. DOI: 10.3390/ijms252413307.


Oxytocin: A Potential Therapeutic for Obesity.

Hong S, Ko J, Moon J, Kim Y J Obes Metab Syndr. 2021; 30(2):115-123.

PMID: 33820878 PMC: 8277591. DOI: 10.7570/jomes20098.


Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives.

Ding C, Magkos F Curr Obes Rep. 2019; 8(3):301-316.

PMID: 31240613 DOI: 10.1007/s13679-019-00355-z.


Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways.

Wang P, Wang S, Yang H, Lv C, Jia S, Liu X Front Neurosci. 2019; 13:454.

PMID: 31178679 PMC: 6537480. DOI: 10.3389/fnins.2019.00454.


Oxytocin in metabolic homeostasis: implications for obesity and diabetes management.

Ding C, Leow M, Magkos F Obes Rev. 2018; 20(1):22-40.

PMID: 30253045 PMC: 7888317. DOI: 10.1111/obr.12757.


References
1.
Farese R, Davis J, Barnes D, Standaert M, Babischkin J, Hock R . The de novo phospholipid effect of insulin is associated with increases in diacylglycerol, but not inositol phosphates or cytosolic Ca2+. Biochem J. 1985; 231(2):269-78. PMC: 1152741. DOI: 10.1042/bj2310269. View

2.
Cherqui G, Caron M, Wicek D, Lascols O, Capeau J, Picard J . Insulin stimulation of glucose metabolism in rat adipocytes: possible implication of protein kinase C. Endocrinology. 1986; 118(5):1759-69. DOI: 10.1210/endo-118-5-1759. View

3.
White J, PLUZNIK D, Ishizaka K, Ishizaka T . Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells. Proc Natl Acad Sci U S A. 1985; 82(23):8193-7. PMC: 391469. DOI: 10.1073/pnas.82.23.8193. View

4.
Yu K, Khalaf N, Czech M . Insulin stimulates a membrane-bound serine kinase that may be phosphorylated on tyrosine. Proc Natl Acad Sci U S A. 1987; 84(12):3972-6. PMC: 305003. DOI: 10.1073/pnas.84.12.3972. View

5.
Thomas T, Gopalakrishna R, Anderson W . Hormone- and tumor promoter-induced activation or membrane association of protein kinase C in intact cells. Methods Enzymol. 1987; 141:399-411. DOI: 10.1016/0076-6879(87)41086-0. View